JAGX
NASDAQ · Pharmaceuticals
Jaguar Health Inc
$2.71
+0.15 (+5.86%)
Open$2.53
Previous Close$2.56
Day High$2.82
Day Low$2.46
52W High$115.50
52W Low$2.12
Volume—
Avg Volume101.7K
Market Cap1.36M
P/E Ratio—
EPS$-713.94
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+1,667.5% upside
Current
$2.71
$2.71
Target
$47.90
$47.90
$35.39
$47.90 avg
$54.68
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 104.18M | 105.51M | 728.2K |
| Net Income | -483,611,179 | -440,804,193 | 171.9K |
| Profit Margin | -464.2% | -441.0% | 23.6% |
| EBITDA | -414,464,424 | -398,765,649 | 249.9K |
| Free Cash Flow | — | — | 132.1K |
| Rev Growth | -1.3% | -1.3% | -5.9% |
| Debt/Equity | 3.64 | 3.64 | 0.52 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,114.20 | +0.64% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $240.15 | +0.45% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $121.17 | +1.31% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.09 | -2.55% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.53 | +1.52% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $78.15 | +1.70% | 12.5 | 33.00B |